🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

315 notícias encontradas para "disease"
Mutations let JC polyomavirus evade antibodies, offering clues for vaccines and treatments
In people with severely compromised immune systems, JC polyomavirus can trigger an untreatable, often fatal brain disease. An international research team has identified how virus mutations can strategically interfere with how human antibodies recognize the virus, allowing it to e
Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma
For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.
TNF-alpha blocks new neurons in hippocampus, reveals inflammation pathway
A molecule linked to chronic inflammation disrupts the brain's ability to create new neurons, uncovering a pathway with therapeutic potential for neurodegenerative diseases and neurological conditions. The King's College London study, published in Nature Communications, offers in
Research improving care for Aboriginal people with diabetes-related foot disease
Research improving care for Aboriginal people with diabetes-related foot disease
A new Kimberley-based study is helping Aboriginal people living with diabetes-related foot disease (DFD) by identifying ways to improve culturally safe care.
Foto: Merlin Lightpainting / Pexels
AI unlocks previously invisible cortical lesions in MS using legacy MRI scans
One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.
New heart disease mechanism revealed: Next-generation targeted therapy shows benefit acros
A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), working in collaboration with an international research team, has identified a new molecular mechanism involved in hypertrophic cardiomyopathy, the most common inherited cardiovascular disea
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Researchers discover potential new treatment for Parkinson's disease, other neurodegenerat
Researchers discover potential new treatment for Parkinson's disease, other neurodegenerat
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.
A rare, Ebola-like virus is spreading. Are we prepared?
A rare, Ebola-like virus is spreading. Are we prepared?
A growing outbreak of the rare Bundibugyo virus in the Democratic Republic of Congo highlights the need for better planning against lesser-known but potentially deadly infectious diseases, according to a review article by Boston University professor Nancy Sullivan, published June
Drug candidate treats severe fatty liver disease by protecting the gut in animal models
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.
Infrared skin sensor tracks deeper hydration at home despite temperature swings
Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear responses to at-home moisturizers, and measurement systems that don't penetrate the deep layers of skin affected by the disease.
First AI agent and risk prediction model for precision diabetes management
First AI agent and risk prediction model for precision diabetes management
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian populations, together with a related disease risk prediction model. Leveraging artifici